CytoDyn to hold Webcast and Live Q/A on Jan 13th
Post# of 148165
(Total Views: 553)
Posted On: 01/11/2022 4:37:34 PM
CytoDyn to hold Webcast and Live Q/A on Jan 13th
VANCOUVER, Washington , Jan. 11, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"
, a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan , Ph.D., President and Chief Executive Officer, Scott Kelly , M.D., Chairman, Chief Medical Officer and Head of Business Development, Nitya Ray , Ph.D., Chief Operating Officer and Chief Technology Officer and Christopher Recknor , M.D., Senior Executive VP of Clinical Operations of CytoDyn will host an investment community webcast to discuss and provide updates with regard to NASH data results (350 and 700 mg), Cancer, COVID-19, HIV BLA, and finances of the Company on Thursday, January 13, 2022 .
CytoDyn will present for 60 minutes, including live questions and answers.
Date:
Thursday, January 13, 2022
Time:
1:00 pm PT / 4:00 pm ET
Access:
https://onlinexperiences.com/Launch/QReg/Show...oupID=Onyx
Interested participants are encouraged to login early prior to the start of the event. This is a livestream presentation, and a link will also be posted on CytoDyn’s website within approximately 48 hours after the presentation.
VANCOUVER, Washington , Jan. 11, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"
, a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan , Ph.D., President and Chief Executive Officer, Scott Kelly , M.D., Chairman, Chief Medical Officer and Head of Business Development, Nitya Ray , Ph.D., Chief Operating Officer and Chief Technology Officer and Christopher Recknor , M.D., Senior Executive VP of Clinical Operations of CytoDyn will host an investment community webcast to discuss and provide updates with regard to NASH data results (350 and 700 mg), Cancer, COVID-19, HIV BLA, and finances of the Company on Thursday, January 13, 2022 . CytoDyn will present for 60 minutes, including live questions and answers.
Date:
Thursday, January 13, 2022
Time:
1:00 pm PT / 4:00 pm ET
Access:
https://onlinexperiences.com/Launch/QReg/Show...oupID=Onyx
Interested participants are encouraged to login early prior to the start of the event. This is a livestream presentation, and a link will also be posted on CytoDyn’s website within approximately 48 hours after the presentation.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼